F. Markus Leweke - Concepedia

Author

F. Markus Leweke

Central Institute of Mental Health ORCID

Also Known As

Corinna I. Bien, F Leweke, F M Leweke, F M. Leweke, F Markus Leweke, F. Leweke, F. M. Leweke, F. MARKUS LEWEKE, F. Markus Leweke, F.M. Leweke

235

Publications

13.2K

Citations

H-Index

132

Concepts

All Affiliations

Central Institute of Mental Health Heidelberg University University of Cologne University Hospital Heidelberg University of Cambridge

About

F. Markus Leweke is an author at Central Institute of Mental Health specializing in medicine, psychiatry, and biological psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	63	6.7K
2	Health Sciences	5	5	272
3	Engineering	3	3	177
4	Natural Sciences	2	2	198
5	Public Health	1	1	161

F. Markus Leweke

112

Publications

10.2K

Citations

H-Index

Page 1

	Year	Citations
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia F. Markus Leweke, Daniele Piomelli, Franziska Pahlisch, Translational Psychiatry Serum Anandamide LevelsPsychopharmacologySocial SciencesCannabidiol EnhancesCannabinoids	2012	1K
Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms Andrea Giuffrida, F. Markus Leweke, C.W. Gerth, Neuropsychopharmacology Acute SchizophreniaPsychiatryPsychotic DisorderPsychopharmacologySchizophrenia	2004	474
Elevated endogenous cannabinoids in schizophrenia F. Markus Leweke, Andrea Giuffrida, U Wurster, Neuroreport	1999	430
Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia Elaine Holmes, Tsz M. Tsang, Jeffrey Huang, PLoS Medicine	2006	287
Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia Emily G. Severance, Kristin L. Gressitt, Cassie Stallings, Schizophrenia Research Medical MicrobiologyMicrobial PathogensInnate Immune ImbalancesPathogenesisImmunology	2013	240
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use F. Markus Leweke, Andrea Giuffrida, Dagmar Koethe, Schizophrenia Research PsychopharmacologySocial SciencesCerebrospinal FluidAddiction MedicinePsychoactive Substance Use	2007	237
Towards a Cannabinoid Hypothesis of Schizophrenia: Cognitive Impairments Due to Dysregulation of the Endogenous Cannabinoid System H. M. Emrich, F. Markus Leweke, Udo Schneider Pharmacology Biochemistry and Behavior NeuropsychologyPsychopharmacologyNeuropsychiatryPsychologyEndogenous Cannabinoid System	1997	226
Antibodies to infectious agents in individuals with recent onset schizophrenia F. Markus Leweke, C.W. Gerth, Dagmar Koethe, European Archives of Psychiatry and Clinical Neuroscience PsychiatryImmunologySerologic TestingRecent Onset SchizophreniaSchizophrenia	2004	222
Gastrointestinal inflammation and associated immune activation in schizophrenia Emily G. Severance, Armin Alaedini, Shuojia Yang, Schizophrenia Research InflammationAutoimmune DiseaseImmune ActivationMucosal ImmunologyImmunology	2012	222
Identification of a biological signature for schizophrenia in serum Emanuel Schwarz, Paul C. Guest, Hassan Rahmoune, Molecular Psychiatry PsychiatryBiological SignatureSchizophreniaNeuroscienceBiological Psychiatry	2011	221

Page 1